XML 137 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 213.9 $ 629.9 $ 813.0
Adjustments to reconcile net income to net cash provided by operating activities and other adjustments:      
Depreciation and amortization 593.1 508.7 481.9
Loss on sale or disposal of fixed assets 1.9 2.4 3.9
Gain on divestiture of business 0.0 (5.0) (12.5)
Loss on debt refinancing and prepayment 6.2 4.6 47.2
Amortization of debt discount and issuance costs 13.0 13.2 16.0
Payments for term debt modification 0.0 (1.1) (3.8)
Share-based compensation expense 79.4 78.3 69.8
Non-cash interest on convertible notes 37.8 36.1 30.8
Non-cash asset impairment charges 3.4 2.4 7.9
Goodwill and intangible asset impairment charges 1.6 6.8 13.1
Change in deferred taxes 11.2 69.2 (348.3)
Other (0.1) (1.6) 2.2
Changes in assets and liabilities (exclusive of the impact of acquisitions and divestitures):      
Receivables 4.7 (2.7) (57.9)
Inventories 34.6 (129.5) (59.9)
Other assets (34.6) (37.4) (86.0)
Accounts payable (79.9) 44.8 51.8
Accrued expenses and other current liabilities (201.7) 56.5 211.1
Deferred income on sales to distributors 0.0 0.0 (109.8)
Other long-term liabilities 10.2 (1.4) 23.7
Net cash provided by operating activities 694.7 1,274.2 1,094.2
Cash flows from investing activities:      
Purchase of property, plant and equipment (534.6) (514.8) (387.5)
Proceeds from sales of property, plant and equipment 1.9 36.5 14.3
Deposits utilized (made) for purchases of property, plant and equipment 4.6 4.1 (8.2)
Purchase of business, net of cash acquired (888.0) (70.9) (0.8)
Purchase of equity interest and assets, net of cash acquired 0.0 (24.6) 0.0
Purchase of license and deposit made for manufacturing facility (100.0) 0.0 0.0
Proceeds from divestiture of business and release of escrow 5.2 8.4 20.0
Proceeds from repayment of note receivable 0.0 10.2 0.0
Other 0.0 2.2 (2.6)
Net cash used in investing activities (1,510.9) (548.9) (364.8)
Cash flows from financing activities:      
Proceeds for the issuance of common stock under the ESPP 26.2 25.0 23.6
Proceeds from exercise of stock options 1.7 5.7 18.0
Payments of tax withholding for restricted shares (33.5) (31.6) (28.1)
Repurchase of common stock (139.0) (315.3) (25.0)
Borrowings under debt agreements 1,404.8 15.3 1,106.2
Payment of debt issuance and other financing costs (24.0) 0.0 0.0
Repayment of long-term debt (594.4) (298.4) (1,831.4)
Release of escrow related to prior acquisition (10.4) 0.0 0.0
Payment of finance lease obligations (0.8) (3.6) (8.9)
Purchase of convertible note hedges 0.0 0.0 (144.7)
Proceeds from issuance of warrants 0.0 0.0 85.2
Payment of contingent consideration 0.0 0.0 (3.9)
Acquisition related payments (5.2) 0.0 0.0
Dividend to non-controlling shareholder (2.3) (2.2) (1.9)
Net cash provided by (used in) financing activities 623.1 (605.1) (810.9)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0.2 0.3 2.3
Net increase (decrease) in cash, cash equivalents and restricted cash (192.9) 120.5 (79.2)
Cash, cash equivalents and restricted cash, beginning of period (Note 18) 1,087.1 966.6 1,045.8
Cash, cash equivalents and restricted cash, end of period (Note 18) $ 894.2 $ 1,087.1 $ 966.6